Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Liang H, Jiang YF, Liu GY, Wang L, Wang JW, Lu N, Xia WX, Ke LR, Ye YF, Duan JL, Bei WX, Dong SH, Li WZ, Liu LT, Zhao C, Xie C, Xiang YQ.
Liang H, et al. Among authors: liu lt.
Nat Commun. 2024 Feb 3;15(1):1029. doi: 10.1038/s41467-024-45126-0.
Nat Commun. 2024.
PMID: 38310101
Free PMC article.
Clinical Trial.